Understanding how different brain cells process amyloid in Alzheimer's disease

Causes and consequences of differential APP processing in inhibitory and excitatory neurons

NIH-funded research Baylor College of Medicine · NIH-11088829

This study is looking at how different brain cells handle a protein linked to Alzheimer's disease, which could help us understand why people experience the disease in different ways and how it affects memory and thinking.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBaylor College of Medicine NIH-funded
Lab location1 site (Houston, United States)
Project IDNIH-11088829 on NIH RePORTER

What this research studies

This research investigates the varying ways in which amyloid precursor protein (APP) is processed in different types of brain cells, specifically excitatory and inhibitory neurons, in the context of Alzheimer's disease. By using newly developed animal models that express APP in either glutamatergic or GABAergic neurons, the study aims to uncover how these differences contribute to the formation of amyloid plaques and the progression of cognitive decline. The researchers will analyze the resulting amyloid structures and their impact on brain function, providing insights into the diverse clinical presentations of Alzheimer's disease.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those at risk for developing it.

Not a fit: Patients with other forms of dementia unrelated to amyloid pathology may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to more targeted therapies for Alzheimer's disease by understanding the cellular mechanisms behind amyloid plaque formation.

How similar studies have performed: Previous research has shown that understanding the cellular mechanisms of amyloid processing can lead to significant advancements in Alzheimer's disease treatment, suggesting this approach has potential for success.

Where this research is happening

Houston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.